Power Law company profile

Aktis Oncology

Biotech & Life Sciences · Boston, United States · Founded 2020 · IPO 2026 Unicorn

Biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals

Valuation

$821M

Market cap · May/2026

Revenue

$6.5M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

14 investors on Aktis Oncology's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 11 investors entered at this stage

Eli Lilly

MPM BioImpact

ArrowMark Partners

Octagon Capital Partners

MRL Ventures

Vida Ventures

Timefolio Capital

EcoR1 Capital

Bristol-Myers Squibb

Novartis

TCGX

Series B+ 3 investors entered at this stage

Janus Henderson Investors

RTW Investments

RA Capital Management

Global footprint

Where Aktis Oncology has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States97.8%

🇨🇦 Canada2.2%

2 countries shown

Web traffic by country

7.1K monthly visits
across markets

🇺🇸 United States93%

🇭🇺 Hungary4.2%

🇩🇪 Germany1.4%

🇵🇭 Philippines0%

Top 4 markets shown

Patent intelligence

$95k patent portfolio · 5 active families

Estimated portfolio value

$95k

0.01% of market cap · 2362.4× smaller than top peer Ganymed Pharmaceuticals ($223M)

5 active patent families

Where Aktis Oncology innovates DiseaseNuclear physicsNuclear medicineRadiochemistryProtide

Where Aktis Oncology concentrates vs peers

Each axis is a top-10 topic across Aktis Oncology and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Aktis Oncology

An AI-synthesized read of the highest-engagement posts about Aktis Oncology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aktis Oncology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles